Stay updated on ABP 798 vs. Rituximab in RA Clinical Trial
Sign up to get notified when there's something new on the ABP 798 vs. Rituximab in RA Clinical Trial page.

Latest updates to the ABP 798 vs. Rituximab in RA Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedUpdated page now communicates government funding lapse impacts and current NIH Clinical Center operating status, and records a new software version (v3.2.0) while removing the old version reference (v3.1.0).SummaryDifference2%

- Check25 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check54 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous location-specific entries across various regions in Poland, Hungary, Germany, and Bulgaria, as well as detailed drug information related to Rituximab and other medical terms. The previous version's content has been streamlined by removing redundant location terms and some drug-related information.SummaryDifference7%

- Check68 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%

Stay in the know with updates to ABP 798 vs. Rituximab in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 798 vs. Rituximab in RA Clinical Trial page.